NOWDiagnostics was pleased to host Viroforge Technologies, LLC at its headquarters in Springdale, AR earlier this October. Dr. Robert Ulrich has been a long-standing scientific collaborator of NOWDiagnostics. While at the Geneva Foundation, his team worked to develop multiplex immunofluorescent diagnostic assays for use with NOWDiagnostics Analyzer technology.
Having recently completed a Phase II SBIR award, the collective team is now actively preparing for The National Institutes of Health Commercialization Readiness Pilot Program submission, due in January 2023. Businesses with an active NIH SBIR or STTR Phase II or Phase IIB contract or grant award from one of the participating NIH Institutes or Centers within the last 36 months are eligible to submit applications for this opportunity. If funded, the award will serve to drive commercialization of the co-developed technologies.
